We hypothesised that hyaluronan (HA) degradation by PEGPH20 may alter tumour viscoelasticity measured by MR elastography (MRE). MRE was performed before and after PEGPH20 in three orthotopic breast tumour models (4T1, 4T1/HAS3 and MDA-MB-231 LM2-4). Viscoelastic properties did not change following PEGPH20 in 4T1 and 4T1/HAS3 tumours. However, a dramatic PEGPH20-induced increase in tumour viscoelasticity was seen in MDA-MB-231 LM2-4 tumours, likely the result of collagen network rearrangement and not HA degradation alone. Although MRE is unlikely to provide a robust biomarker of PEGPH20 response, these data clearly demonstrate that MRE-derived biomarkers can inform on increased tumour stiffness in vivo.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords